Skip to main content
LAB logo

LAB · Standard Biotools Inc. · Analyst Estimates

Track LAB — free
$0.79 +0.04 (+5.53%) At close · Oct 5
Market Cap
$290.47M
Shares
392.58M
Volume · Oct 5 1.18M Avg daily vol (3M) 1.68M

Analyst Estimates

Compare analyst forecasts for Standard Biotools Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 12:43 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.1
-0.1
-0.1
—
-0.16
-0.16
-0.16
-0.155
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
82500000
82500000
82500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.16
-0.16
-0.16
—
-0.13
-0.145
-0.14
-0.14
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
1
Revenue
USD
Publication date not stated
82100000
82100000
82100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.02
-0.02
-0.02
—
-0.035
-0.035
-0.035
-0.035
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
18800000
18800000
18800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.02
-0.02
-0.02
—
-0.03
-0.03
-0.03
-0.03
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
21000000
21000000
21000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —
Key facts CIK 1162194 CUSIP 34385P108 13F (30d) 1 filings 1 filers Visit website Investor relations